Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present DarioHealth Corp. (NASDAQ: DRIO).

Full DD Report for DRIO

You must become a subscriber to view this report.


Recent News from (NASDAQ: DRIO)

DarioHealth to Host Third Quarter 2018 Conference Call on November 13, 2018
NEW YORK and CAESAREA, Israel , Nov. 6, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its third quarter 2018 results on Tuesday, November 13 , and host ...
Source: PR Newswire
Date: November, 06 2018 08:00
DarioHealth Launches Integrated Diabetes Digital Health Solution Including Version 4.1 of Its Award-winning Dario App and DarioEngage Patient Coaching Platform
CAESAREA , Israel , Oct. 25, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch of version 4.1 of its award-winning Dario ® App for the Dario Blood Glucose Moni...
Source: PR Newswire
Date: October, 25 2018 08:00
DarioHealth to Host Investor Conference Call on October 4, 2018
CAESAREA, Israel , Sept. 20, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will host a conference call to provide a business update for investors at 9:00am ED...
Source: PR Newswire
Date: September, 20 2018 08:00
DarioHealth Closes on $10,345,000 Through Private Placement Offering
CAESAREA, Israel , Sept. 14, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it has closed on a private placement offering with institutional and private investors for ...
Source: PR Newswire
Date: September, 14 2018 08:00
DarioHealth appoints Olivier Jarry as President and COO
DarioHealth Corp. (NASDAQ: DRIO ) announces that Olivier Jarry has joined the Company as President and Chief Commercial Officer. More news on: DarioHealth Corp., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: September, 05 2018 08:15
DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer
CAESAREA, Israel , Sept. 5, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Olivier Jarry , a prominent global life sciences and consumer health executive, has joined the...
Source: PR Newswire
Date: September, 05 2018 07:00
DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management
CAESAREA, Israel , Aug. 22, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has entered into an agreement with Attain Health , a provider of integrative health coaching for indi...
Source: PR Newswire
Date: August, 22 2018 08:00
Midday Gainers / Losers (08/20/2018)
Gainers:  SSC +66% . GRIN +48% . CMCM +20% . ALRN +19% . AGMH +15% . TLRY +15% . CRON +14% . SALM +13% . CHMA +13% . GWGH +12% . More news on: Seven Stars Cloud Group, Inc., Grindrod Shipping Holdings Ltd., Cheetah Mobile Inc., Stocks on the move, , ...
Source: SeekingAlpha
Date: August, 20 2018 12:54
DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore
CAESAREA, Israel , Aug. 15, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health products at the American Associatio...
Source: PR Newswire
Date: August, 15 2018 08:30
DarioHealth Corp. (DRIO) CEO Erez Raphael on Q2 2018 Results - Earnings Call Transcript
DarioHealth Corp. (DRIO) Q2 2018 Earnings Conference Call August 9, 2018 9:00 A.M. ET Executives Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Analysts Steve Wardell - Chardan Jeff Silver - Berson and Corrado Kyle Krueger - Apollo Capital...
Source: SeekingAlpha
Date: August, 13 2018 06:46

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-130.790.77010.81470.730125,869
2018-12-120.72440.760.7980.724445,038
2018-12-110.74840.700.74840.7034,047
2018-12-100.760.7940.800.765,143
2018-12-070.8250.790.8860.7918,750

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-135003,50014.2857Cover
2018-12-1223,55034,10969.0434Short
2018-12-116008,4787.0771Cover
2018-12-103352,92211.4648Cover
2018-12-072,33111,12020.9622Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on DRIO.


About DarioHealth Corp. (NASDAQ: DRIO)

Logo for DarioHealth Corp. (NASDAQ: DRIO)

We are a mobile health mHealth company developing and commercializing patented technology providing consumers with laboratory testing capabilities using smart phones and other mobile devices. We were formed in August as a Delaware corporation. Our initial product is Dario TM , a mobile, cloud based, diabetes management solution which includes novel software applications combined with a stylish, all in one , pocket sized, blood glucose monitoring device which we call our Dario TM Smart Meter that will compete in the estimated billion dollar worldwide market for patient self monitoring of blood glucose which we refer to as SMBG products. Dario TM is a comprehensive system incorporating patented technology that combines a cutting edge software application and cloud based data services with a novel all in one Dario TM Smart Meter consisting of a lancet to obtain a blood sample , a device specific disposable test strip cartridge and a smartphone driven glucose reader adaptor.

 

 

 

Current Management

  • Erez Raphael / President, CEO
  • Zvi BenDavid / CFO, Secretary, Treasurer
  • Ronen Raviv / Corporate Controller
  • Erez Raphael / Chairman
  • Dr. Malcolm Hoenliein /
  • Hila Karah /
  • Dennis M McGrath / Director
    • Dennis M. McGrath was appointed to our Board in July . He served as our President and Chief Financial Officer from January until May , he previously was CEO and President from July through December , and CFO and Vice President, finance and administration from January through June . From February to January , he served as COO of Internet Practice, the largest division for AnswerThink Consulting Group, Inc. and from August until January , as CFO of Think New Ideas, Inc. He was responsible for the merger integration of Think New Ideas and AnswerThink. He was CFO and executive vicepresident, operations of TriSpan, Inc. from September to February , an internet commerce solutions and technology consulting company acquired by AnswerThink in . Mr. McGrath is currently a director of Noninvasive Medical Technologies, Inc., Dario Health, Inc. formerly LabStyle, Inc. and Cagent Vascular, Inc. and serves on the Board of Trustees for Manor College and the Board of Visitors for Taylor University. He is currently CFO of PAVMed, Inc. Mr. McGrath graduated with a B.S. in accounting from LaSalle University in and became a Certified Public Accountant in and holds inactive licenses in Pennsylvania and New Jersey.
  • Richard Stone /
  • Rami Yehudiha /

Current Share Structure

  • Market Cap: $21,420,324 - 03/16/2018
  • Authorized: 160,000,000 - 03/01/2018
  • Issue and Outstanding: 14,185,645 - 03/01/2018

 


Recent Filings from (NASDAQ: DRIO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 05 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 06 2018
Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: May, 31 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 25 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 24 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 21 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: May, 16 2018

 

 


Daily Technical Chart for (NASDAQ: DRIO)

Daily Technical Chart for (NASDAQ: DRIO)


Stay tuned for daily updates and more on (NASDAQ: DRIO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: DRIO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DRIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of DRIO and does not buy, sell, or trade any shares of DRIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/